MZ Biolabs
U.S. analytical testing lab that explicitly offers COA testing for peptides and other research compounds using HPLC and mass spectrometry.
358 attributable certificates
Observed across 12 vendors in PeptideBenchmark’s public COA archive.
0.0% connect to a lab-controlled lookup. No automated lookup-health sample is available.
First and latest attributable certificate observations.
5 records share a current document fingerprint.
Vendor-hosted document only. Record-level confirmation remains separately labeled.
19 unresolved · grouped duplicate, reuse, chronology, and quantity checks
Open review queue →Readers who want a named lab partner signal attached to a cleaner public-disclosure-first vendor pattern.
MZ matters in the current graph, but its recurring public vendor-link density is still thinner than Janoshik or TrustPointe.
This label reflects how the provider presents itself on its own site today, not a formal accreditation category.
Whether the site appears to invite direct sample submission from individuals rather than only business or institutional clients.
Whether the provider appears to offer public-facing report publishing, result browsing, or direct verification tooling.
This is our shorthand for how visible the provider's result or verification layer appears to be, ranging from none to searchable public verification.
Location details are kept conservative and only shown when clearly supported by the source page or the provider’s public materials.
This provider is part of the current testing-provider comparison layer because it anchors a meaningful part of the vendor transparency graph, not just because it has a standalone profile.
Strongest current vendor links: Pure Peptides Bio.
Readers who want a named lab partner signal attached to a cleaner public-disclosure-first vendor pattern.
MZ matters in the current graph, but its recurring public vendor-link density is still thinner than Janoshik or TrustPointe.
Classic lab-style profiles matter because they anchor the analytical side of the ecosystem, even when their public verification layer is thinner than the strongest platform-style entries.
- The core signal is analytical capability and service framing rather than flashy public report tooling.
- These profiles are especially useful when they recur as named labs inside vendor-facing archives or provider-authored reports.
- A thinner public publishing layer does not make the lab unimportant; it just means readers need to interpret it differently.
What we can verify now
MZ Biolabs publicly states that it offers analytical testing for peptides and other research compounds using HPLC with UV detection and mass spectrometry.
Its public COA testing page explicitly says it can:
- confirm identity and specifications
- test purity of raw powders and liquids
- quantify formulated compounds
- and issue certificates of analysis for those compound classes
The public site also lists a Tucson, Arizona address.
Coverage notes
- Confirmed no public verification portal: we checked the MZ Biolabs site directly — the COA-testing page is a service description with a client login, not a searchable lookup, so a reader cannot independently pull a certificate by code
- In practice its COAs pair an HPLC-UV-MS purity page with a separate mass-spectrometry identity page (a two-page certificate), seen on curated SARM/peptide vendors
- The site language is business-facing, so direct one-off consumer intake should be treated as unconfirmed
Why it matters in the current vendor graph
MZ Biolabs is important because it helps define the disclosure-first end of the testing spectrum.
In the current PeptideBenchmark network, MZ tends to matter when a vendor names a real outside lab partner publicly even if the vendor does not expose a deep public verification portal or a giant public archive. That makes MZ useful as a signal of lab specificity, even when the surrounding evidence is lighter than the Janoshik or TrustPointe patterns.
What to watch for
Readers should avoid over-reading this kind of provider signal. A named lab partner is better than vague “third-party tested” language, but it is still a different transparency level from openly inspectable report libraries or public verification pages.